Douglass Winthrop Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $438K | Sell |
1,125
-337
| -23% | -$131K | 0.01% | 197 |
|
|
2025
Q1 | $636K | Sell |
1,462
-50
| -3% | -$21.7K | 0.01% | 172 |
|
|
2024
Q4 | $558K | Hold |
1,512
| – | – | 0.01% | 199 |
|
|
2024
Q3 | $786K | Hold |
1,512
| – | – | 0.02% | 166 |
|
|
2024
Q2 | $819K | Hold |
1,512
| – | – | 0.02% | 148 |
|
|
2024
Q1 | $784K | Buy |
1,512
+187
| +14% | +$97K | 0.02% | 154 |
|
|
2023
Q4 | $625K | Hold |
1,325
| – | – | 0.01% | 157 |
|
|
2023
Q3 | $577K | Hold |
1,325
| – | – | 0.01% | 152 |
|
|
2023
Q2 | $589K | Hold |
1,325
| – | – | 0.01% | 160 |
|
|
2023
Q1 | $609K | Sell |
1,325
-36
| -3% | -$16.5K | 0.02% | 153 |
|
|
2022
Q4 | $698K | Hold |
1,361
| – | – | 0.02% | 143 |
|
|
2022
Q3 | $618K | Hold |
1,361
| – | – | 0.02% | 142 |
|
|
2022
Q2 | $657K | Hold |
1,361
| – | – | 0.02% | 149 |
|
|
2022
Q1 | $669K | Sell |
1,361
-114
| -8% | -$56K | 0.02% | 165 |
|
|
2021
Q4 | $684K | Hold |
1,475
| – | – | 0.02% | 167 |
|
|
2021
Q3 | $550K | Sell |
1,475
-26
| -2% | -$9.7K | 0.01% | 186 |
|
|
2021
Q2 | $573K | Buy |
1,501
+226
| +18% | +$86.3K | 0.01% | 185 |
|
|
2021
Q1 | $458K | Hold |
1,275
| – | – | 0.01% | 197 |
|
|
2020
Q4 | $409K | Hold |
1,275
| – | – | 0.01% | 207 |
|
|
2020
Q3 | $342K | Hold |
1,275
| – | – | 0.01% | 212 |
|
|
2020
Q2 | $335K | Buy |
+1,275
| New | +$335K | 0.01% | 202 |
|